Skip to main content

ORIGINAL RESEARCH article

Front. Neurol., 12 December 2022
Sec. Applied Neuroimaging
This article is part of the Research Topic Neuroimaging Findings in Chronic diseases, Volume 2 View all 8 articles

Altered functional hubs and connectivity in type 2 diabetes mellitus with and without mild cognitive impairment

\nYang Huang&#x;Yang Huang1Dongsheng Zhang&#x;Dongsheng Zhang1Xin ZhangXin Zhang1Miao ChengMiao Cheng1Zhen YangZhen Yang1Jie GaoJie Gao1Min TangMin Tang1Kai AiKai Ai2Xiaoyan Lei
Xiaoyan Lei1*Xiaoling Zhang
Xiaoling Zhang1*
  • 1Department of MRI, Shaanxi Provincial People's Hospital, Xi'an, China
  • 2Department of Clinical and Technical Support, Philips Healthcare, Xi'an, China

Cognitive impairment in type 2 diabetes mellitus (T2DM) is associated with functional and structural abnormalities of brain networks, especially the damage to hub nodes in networks. This study explored the abnormal hub nodes of brain functional networks in patients with T2DM under different cognitive states. Sixty-five patients with T2DM and 34 healthy controls (HCs) underwent neuropsychological assessment. Then, degree centrality (DC) analysis and seed-based functional connectivity (FC) analysis were performed to identify the abnormal hub nodes and the FC patterns of these hubs in T2DM patients with mild cognitive impairment (MCI) (DMCI group, N = 31) and without MCI (DMCN group, N = 34). Correlation analyzes examined the relationship between abnormal DC and FC and clinical/cognitive variables. Compared with HCs, both T2DM groups showed decreased DC values in the visual cortex, and the T2DM patients with MCI (DMCI) showed more extensive alterations in the right parahippocampal gyrus (PHG), bilateral posterior cingulate cortex (PCC), and left superior frontal gyrus (SFG) regions than T2DM patients with normal cognitive function. Seed-based FC analysis of PHG and PCC nodes showed that functional disconnection mainly occurred in visual and memory connectivity in patients with DMCI. Multiple abnormal DC values correlated with neuropsychological tests in patients with T2DM. In conclusion, this study found that the DMCI group displayed more extensive alterations in hub nodes and FC in vision and memory-related brain regions, suggesting that visual-related regions dysfunctions and disconnection may be involved in the neuropathology of visuospatial function impairment in patients with DMCI.

Introduction

Type 2 diabetes mellitus (T2DM) is a common systemic metabolic disease characterized by chronic hyperglycemia and insulin resistance (1). Long-term hyperglycemia can lead to various cognitive dysfunctions involving attention, memory, and visual space in patients with T2DM (2, 3). In addition, between 10.8% and 17.5% of patients with T2DM eventually develop mild cognitive impairment (MCI) and dementia (4). However, the neural mechanism of cognitive impairment in T2DM remains unclear. Abnormal changes in brain structure and function are the neural basis of cognitive impairment, especially damage to brain hub nodes and networks (5). Studies (6, 7) have found that cognitive dysfunction associated with different stages of diabetes have different features, and cognitive impairment caused by hyperglycemia may involve a complex process (8). Therefore, it is necessary to explore the patterns of brain function change in patients with T2DM under different cognitive states and comprehensively examine the neural mechanism of cognitive impairment in patients with T2DM.

Many neuroimaging studies have used different methods to explore the patterns of abnormal brain structure and function in patients with T2DM under different cognitive states. Voxel-based morphometry (VBM) analysis has found reductions in cortical/subcortical gray matter and some overlapping brain regions in T2DM patients with and without MCI, whereas gray matter volume (GMV) atrophy is more widespread in T2DM patients with MCI (DMCI) (9, 10). Li et al. (10) suggested that subcortical atrophy may play a pivotal role in the cognitive impairment of patients with T2DM. Furthermore, several studies using different methods found slight changes in the white matter microstructure (1113) and the white matter structure network (14, 15) in T2DM patients with normal cognitive function (DMCN), whereas patients with DMCI have extensive white matter abnormalities, suggesting that white matter microstructural and structure network change might give rise to cognitive impairment in patients with T2DM. Although the previous studies have revealed extensive changes in the brain structure of patients with T2DM under different cognitive states and reached relatively consistent conclusions, the results of studies on brain function in different cognitive states of patients with T2DM are inconsistent. For example, an fMRI study (16) indicated that the brain regions that have abnormal neuron activity are mostly the same in patients with T2DM under different cognitive states. Another study (17) found that patients with DMCI exhibited more extensively altered regional homogeneity and impaired network organization relative to patients with DMCN, suggesting that there may be a compensation mechanism in the development of cognitive impairment in T2DM. Moreover, an analysis of brain network connectivity showed more extensive impaired intra-network and inter-network connectivity in patients with DMCI (18). Zhang et al. (19) demonstrated, using independent component analysis (ICA), that patients with DMCI exhibited weakened functional connectivity (FC) and reduced GMV within the salience network (SN), whereas patients with DMCN exhibited enhanced intra-SN functional coupling, which suggests that changes in intra-SN FC and GMV were non-linear and complex in patients with T2DM and cognitive impairment. However, few studies have focused on changes in the patterns of brain hub nodes and their effects on the FC of the whole brain of patients with T2DM under different cognitive states. Previous studies have used degree centrality (DC) analysis to investigate the abnormalities of hub nodes in patients with T2DM, and their results suggested these abnormalities may reflect the aberrant communication of information in the brain of patients with T2DM (20, 21). Nonetheless, at the same baseline level, changes in patterns of hub nodes and their FC in the whole brain of patients with T2DM under different cognitive states are still unclear.

Degree centrality (DC) is a powerful measure that reflects abnormalities in the most connected hub nodes in functional networks (22, 23); this method can avoid the deviations caused by selecting brain regions based on prior hypotheses. In addition, as the brain is a complex system, it is essential not only to look at the individual regions but also to explore how brain networks work together through signal coherence (24). Brain network dysfunction and abnormal neuronal activity are the basis of cognitive impairment, and combing DC with secondary seed-based FC analysis can effectively detect abnormal neural network connections (25, 26).

In this study, we used both DC analysis and seed-based FC analysis to reveal the relationships among hub nodes and related network dysfunction and cognitive impairment in patients with T2DM. The key neuropathological features of cognitive impairment in patients with T2DM are advanced glycation end-products and amyloid-beta deposition, and some studies indicate that the cognitive dysfunction caused by amyloid-beta deposition is a non-linear process (27, 28). Based on previous fMRI studies and the neuropathological basis of cognitive impairment, we speculated that the patterns of brain functional changes in patients with T2DM under different cognitive states may be complex and diverse, but abnormalities of brain hub nodes and functional connections may be more extensive in patients with DMCI. Furthermore, these abnormally altered hub nodes and functional connections may correlate with clinical/cognitive variables.

Materials and methods

Participants

Sixty-seven patients with T2DM were recruited for this study from May 2019 to July 2020 at Shaanxi Provincial People's Hospital, including 33 patients with MCI (DMCI group) and 34 patients without MCI (DMCN group). Thirty-four healthy controls (HCs) were recruited from the health examination center of our hospital. All participants were between 45 and 70 years of age, right-handed, and had at least 6 years of education. The diagnostic criteria of T2DM were based on the American Diabetes Association's 2014 guidelines. Patients with T2DM were on stable therapy (diet, oral medications, and/or insulin). Patients with T2DM were excluded who had a history of hypoglycemia (blood glucose concentration of < 3.9 mmol/L) or hyperglycemia (blood glucose concentration of >33.3 mmol/L). The inclusion criteria of the DMCI group were: (1) complaints of hypomnesis, which occurred after a clinical diagnosis of T2DM; (2) an MMSE score >24 and MoCA score < 26; (3) no other physical, mental, or neurological disorders that could lead to cognitive impairment. The exclusion criteria for all the participants were: (1) severe claustrophobia or contraindications for MRI; (2) alcoholism, Parkinson's disease, major depression, brain injury, epilepsy, or other neurological or psychiatric disorders; (3) any other systemic disease.

Every participant arrived at the department for MRI at 6:30–7:00 p.m. after dinner and controlled their blood glucose according to their doctor's orders on the day of the scan. MRI was performed after ~30 min of structured clinical interview and a series of psychological tests. The test procedure and scan time of the HCs were the same as those of patients with T2DM. Only one participant was scanned each day to ensure that each participant completed the examination with relatively stable blood glucose. The study was approved by the ethics committee of Shaanxi Provincial People's Hospital, and written informed consent was obtained from all the participants. All methods were performed in accordance with relevant guidelines and regulations according to the Declaration of Helsinki.

Clinical data and neuropsychological test information

All participants underwent the following neuropsychological examinations: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Clock-Drawing Test (CDT), and Trail-Making Test A (TMT-A). TMT-A was used to test information processing speed and attention, and the increased time patients spend on the TMT-A test indicates that their attention and psychomotor speed are abnormal (29). CDT is often significantly associated with visuospatial and executive function, so it is commonly used to assess these cognitive domains (30). The neuropsychological tests were performed by a psychiatrist with more than 5 years of experience. HCs data were collected from the outpatient medical examination center. The participants' medical history and clinical data, including blood pressure, height, weight, and body mass index (BMI), were obtained from medical records and questionnaires. In addition, glycated hemoglobin (HbA1c), fasting blood glucose (FBG) concentration, triglyceride concentration, cholesterol concentration, and low-density lipoprotein cholesterol concentration were measured by standard laboratory tests.

Image acquisition

The MRI images were acquired using a 3.0T MR scanner (Ingenia, Philips Healthcare, The Netherlands) with a 16-channel phased array head coil. Routine T2-weighted and fluid-attenuated inversion recovery (FLAIR) sequence (slices = 18, thickness = 6 mm, gap = 1 mm) were used to exclude visible brain lesions. The age-related white matter change scale (31) was used to evaluate lacunar infarcts and white matter hyperintensity based on FLAIR images; participant with a score >2 was excluded. Resting-state functional MRI (rs-fMRI) images were acquired using a gradient echo planar sequence with the following parameters: repetition time (TR) = 2,000 ms, echo time (TE) = 30 ms, flip angle (FA) = 90°, field of view (FOV) = 230 mm × 230 mm, matrix = 128 × 128, slices = 34, thickness = 4 mm (no gap), axial interleaved acquisition, and 200 volumes were acquired in each scan. Sagittal 3D T1-weighted images were acquired using a fast spoiled gradient echo sequence with the following parameters: TR = 7.5 ms, TE = 3.5 ms, FA = 8°, FOV = 250 mm × 250 mm, matrix = 256 × 256, slice thickness = 0.55 mm (no gap), and 328 sagittal slices. All participants were instructed to close their eyes and stay awake throughout the scan.

Preprocessing of MRI data

The rs-fMRI data were preprocessed by the DPABI (http://rfmri.org/dpabi/) software package (32). The first 10 time points were discarded to ensure the stability of the magnetic field. The slice-timing and realignment of head motion correction were performed for the remaining 190 time points. Participants were excluded from this study whose head motion >1.5 mm and/or translation >1.5° rotation. Moreover, the scrubbing method was used to reduce the effect of high-head motion (33). We calculated the frame-wise displacement (FD) and set an FD threshold for bad volumes as 0.2 mm. The bad volumes were scrubbed which the FD values were greater than 0.2 mm, as well as one forward volume and two back volumes of the bad volumes. Then, each bad volume was modeled as a regressor in the model regression (34). Then, the images were normalized to the standard Montreal Neurological Institute (MNI) space with an echo planar imaging (EPI) template (resampling voxel size = 3 mm × 3 mm × 3 mm). In addition, we regressed out 24 head motion parameters, the linear trend signal, cerebrospinal fluid signals, and white matter signals. Finally, a temporal-band filter (0.01–0.08 Hz) was used to regress the effect of physiological noise.

Degree centrality analysis

Differences in the brain functional hubs were obtained by comparing the DC maps of the three groups. First, a voxel-based correlation analysis of whole-brain function was performed on the preprocessed fMRI data, and Pearson's correlations were calculated for the time course from each voxel to every other voxel in the whole brain to create a correlation matrix. Second, the binarized matrix was obtained by thresholding each correlation at r > 0.25 (35, 36). Then, these voxel-wise DC values were converted into a z-score matrix to improve normality. Finally, the zDC maps were further smoothed (FWHM = 6 mm) for statistical analysis.

Seed-based functional connectivity analysis

A seed-based approach was used for FC analyzes of the spatial smoothing (FWHM = 6 mm) data. The peak MNI coordinates of significantly altered DCs between the DMCI and DMCN groups were selected as the center of spherical regions of interest (ROIs) with a 6-mm radius. Then, the time courses were extracted for the ROIs, and correlations were calculated between each ROI and every other voxel within the brain to obtain FC maps. These FC maps were converted to z-score maps using Fisher's z transformation to improve the normality.

Statistical analysis

The chi-square (χ2) test was used to analyze the sex-based differences among the three groups. One-way analysis of variance (ANOVA) was used to analyze other demographic and clinical and cognitive scores. A two-sample t-test was used to compare disease duration between the DMCI and DMCN groups. These analyzes were performed using SPSS version 24 (IBM Corporation, Armonk, NY, United States), and P < 0.05 was considered to be statistically significant.

The statistical analyzes of DC and seed-based FC were performed in DPABI software. Analysis of covariance (ANCOVA) was performed to investigate the regions with significant differences in DC and FC among the three groups, with age, gender, and years of education as covariates (P < 0.001, uncorrected, cluster >50). The ANCOVA results were used as a mask, and post-hoc analyzes within the areas were performed to investigate pairwise between-group differences (FDR corrected, P < 0.05).

Correlation analysis of average zDC and zFC values of the brain areas with significant differences was extracted from the DMCI and DMCN groups. Then, significant partial correlations (Bonferroni corrected, P < 0.05/13) were performed between the zDC values, zFC values, and clinical scores, with age, gender, and years of education as covariates.

Results

Clinical and neuropsychological data comparison

Two patients with DMCI were excluded from the analyzes for excessive motion; thus, 31 patients with DMCI, 34 patients with DMCN, and 34 HCs were included in the analyzes. There were no significant group differences in gender, age, education, blood pressure, BMI, triglycerides, total cholesterol, or low-density lipoprotein. Compared with HCs, the two T2DM groups showed higher FBG and HbA1c scores. Analysis of the neuropsychological data revealed the DMCI group had poorer MMSE, MoCA, and CDT scores and higher TMT-A scores compared to the DMCN group and HCs (see Table 1).

TABLE 1
www.frontiersin.org

Table 1. Demographic, clinical, and neuropsychological characteristics of the participants.

Degree centrality analysis

Compared to the HCs, the DMCI group showed decreased zDC values in the right parahippocampal gyrus (PHG), fusiform gyrus (FFG), and middle occipital gyrus (MOG), the bilateral calcarine (CAL), and the posterior cingulate cortex (PCC), whereas the DMCN group showed increased zDC in the left superior frontal gyrus (SFG) and decreased zDC in the bilateral CAL and right MOG. Compared with the DMCN group, the DMCI group showed decreased zDC in the right PHG, bilateral PCC, and left SFG (see Table 2, Figure 1). In addition, the zDC values in the right FFG were negatively correlated with CDT scores of patients with DMCI (r = −0.554, P = 0.001) (Figure 2A). Moreover, the zDC values in the bilateral CAL were negatively correlated with the HbA1c scores of patients with DMCI (r = −0.553, P = 0.001) (Figure 2B).

TABLE 2
www.frontiersin.org

Table 2. Significant differences in DC.

FIGURE 1
www.frontiersin.org

Figure 1. DC analysis of the three groups. (A) Significant difference in DC among three groups (P < 0.001, uncorrected, cluster >50). (B) Significant difference in DC between the DMCI and HC groups. (C) Significant difference in DC between the DMCN and HC groups. (D) Significant difference in DC between the DMCI and DMCN groups (P < 0.05, FDR corrected). Warm (cold) color indicates significantly increased (decreased) DC.

FIGURE 2
www.frontiersin.org

Figure 2. Correlations between DC values and clinical/cognitive variables. (A) Correlation between DC values in the right FFG and CDT scores in patients with DMCI (r = −0.554, P = 0.001). (B) Correlation between DC values in the bilateral CAL and HbA1c scores of patients with DMCI (r= −0.553, P = 0.001). The asterisk (*) indicates coordinate values, controlling for the effects of gender, age, and years of education.

Seed-based functional connectivity analysis

Three regions (the right PHG, bilateral PCC, and left SFG) were selected as ROIs to perform voxel-wise FC analyzes. The analyzes revealed between-group differences in the right PHG, as shown in Figure 3, Table 3. Compared to HCs, both T2DM groups showed decreased FC between the right PHG and FFG. The DMCI group also had significantly weaker FC values between the right PHG and left angular gyrus than the DMCN and HC groups. Moreover, FC analysis of the bilateral PCC showed reduced FC in the right middle temporal gyrus (MTG) and left MOG in the DMCI group, and the DMCN group showed increased FC in the left SFG compared with HCs. Compared to the DMCN group, the DMCI group showed reduced FC in the bilateral PCC and right MTG (Figure 4, Table 4). The seed-based FC analysis of the SFG found no significant differences among the three groups.

FIGURE 3
www.frontiersin.org

Figure 3. Seed-based FC analysis in the right PHG of the three groups. (A) Significant difference in FC among three groups (P < 0.001, uncorrected, cluster >50). (B) Significant difference in FC between the DMCI and HC groups. (C) Significant difference in FC between the DMCN and HC groups. (D) Significant difference in FC between the DMCI and DMCN groups (P < 0.05, FDR corrected). Warm (cold) color indicates significantly increased (decreased) FC.

TABLE 3
www.frontiersin.org

Table 3. Significant differences in FC in the right PHG.

FIGURE 4
www.frontiersin.org

Figure 4. Seed-based FC analysis in the bilateral PCC of the three groups. (A) Significant difference in FC among three groups (P < 0.001, uncorrected, cluster >50). (B) Significant difference in FC between the DMCI and HC groups. (C) Significant difference in FC between the DMCN and HC groups. (D) Significant difference in FC between the DMCI and DMCN groups (P < 0.05, FDR corrected). Warm (cold) color indicates significantly increased (decreased) FC.

TABLE 4
www.frontiersin.org

Table 4. Significant differences in FC in the bilateral PCC.

Discussion

In our study, we combined DC analysis and voxel-wise FC analysis to explore abnormal hub nodes and the FC patterns of these hubs in patients with T2DM under different cognitive states. There were two main sets of results. First, decreased DC values were found in the visual cortex of both T2DM groups, and the DMCI group showed more extensive alterations of brain hub regions in the right PHG, bilateral PCC, and left SFG regions than in the DMCN group. Second, the seed-based FC analysis further suggested that there are functional connectivity disturbances in visuospatial and memory-related brain connectivity in patients with DMCI.

DC alterations

We found decreased DC values in the bilateral CAL and right MOG in both T2DM groups. These two regions are thought to be involved in processing visual information and encoding visual memories (37). Visual function impairment exists in the early stage of patients with T2DM (38, 39) and long-term hyperglycemia is the main factor leading to visual cognitive impairment (40, 41). The correlation results of the present study also suggested that the functional abnormalities of bilateral CAL may be affected by HbA1c in patients with DMCI. In addition, we found that patients with DMCI exhibited decreased DC values in right FFG and correlated with worse CDT scores. Those evidence suggest that visuospatial impairment is more widespread in patients with DMCI. The right FFG is involved in visuospatial function (42), and alterations in the FFG can cause visual cognitive impairment in patients with MCI, especially facial cognition (43, 44).

The brain regions of PHG, PCC, and SFG are the core nodes in declarative memory (45), default mode network (46), and executive control functions (47), respectively. These brain regions play an important role in maintaining higher cognitive functions. Chronic hyperglycemia can affect hub nodes and disrupt the topological integration of the brain (48), which may be the reason for the decreased DC values of these nodes in the DMCI group compared with the DMCN group. The results of this study suggest that patients with DMCI have more abnormal higher cognitive function brain regions. Interestingly, compared with HC, the DC value of SFG in the DMCN group increased, which may suggest that patients with T2DM had abnormal changes in brain function before MCI. Multiple previous studies have found increased FC in the SFG in patients with subjective cognitive impairment (49, 50). The different patterns of changes in the SFG in the two groups of patients with T2DM seem unusual, but this may suggest that the changes in the SFG under different cognitive states may be a complex process. Multiple studies have demonstrated that the impairment of brain function may not be a linear process (51, 52), which may be the reason why the SFG was not significantly different among groups in subsequent FC analysis. In addition, the present study also found that patients with DMCI showed worse psychomotor speed and attention, which is consistent with previous findings (53, 54) that patients with MCI are often accompanied by the impairment of multiple cognitive domains.

FC alterations in the right PHG

In our study, both T2DM groups showed reduced connectivity between the right PHG and right FFG. The FFG connects with the medial temporal lobe, including the PHG, which is related to visual working memory and visual-spatial abilities (55). A neuropathological study suggested that the Tau protein levels in the FFG and PHG were associated with longitudinal visuospatial cognitive decline in patients with AD (56). The pathological mechanism of cognitive impairment in T2DM is similar to that of AD (57), which may suggest that the disordered functional connectivity of PHG and right FFG is related to the abnormal visuospatial function of patients.

The angular gyrus is connected to both the PHG and hippocampus via the inferior occipitofrontal fasciculus (58, 59), and it plays a critical role in memory retrieval (60, 61). The angular gyrus, hippocampus/parahippocampal gyrus, and dorsomedial prefrontal cortex are activated during episodic autobiographical memory (62). Moreover, the parahippocampal region exhibits strong connectivity with the angular gyrus during episodic memory retrieval processing (63). Studies (2, 64) suggest that episodic memory dysfunction exists in patients with T2DM. The current study found that the DMCI group showed lower FC values in the right PHG and left angular gyrus than the DMCN and HCs groups, suggesting that patients with DMCI may have a dysfunction in episodic memory retrieval.

FC alterations in the bilateral PCC

Research has confirmed that the spontaneous activity of the MTG is strongly correlated with semantic processing efficiency (65). Patients with MCI showed less effective connectivity between the MTG and PCC, and this impaired connectivity is correlated with cognitive performance during auditory verbal learning (66). Our study found the PCC showed reduced FC with the right MTG in the DMCI group. This is consistent with previous findings (67, 68), which may suggest abnormal semantic memory functioning in patients with DMCI.

The MOG is involved in visual processing, and patients with MCI show reduced connectivity between the PCC and MOG during visual cognitive tasks, which is associated with impaired visual processing (69). Consistent with the previous DC results, FC analysis further confirmed that visual impairment was more severe in patients with DMCI. In addition, similar to previous research (67), we found increased FC values between the PCC and left SFG in the DMCN group, which may be interpreted as a compensatory increase in patients' cognitive control of food. The SFG and PCC/precuneus play important roles in the cognitive control circuit, supporting cognitive control of appetite upon encountering visual food cues. It was found that neuropeptide oxytocin (OXT) was able to reduce food craving trends under cognitive control conditions and that the effects of OXT paralleled increased activity in the SFG, precuneus, and cingulate cortex (70).

Limitations

This study has several limitations. First, this experiment is a cross-sectional study with a small sample size, and a larger sample could increase the credibility of our results. Second, although we adopted a relatively loose correction method in the ANCOVA analysis, the post-hoc analysis adopted strict FDR correction, which could minimize the false positive of between-group differences. Third, many of the patients in this study received various medications that may have biased the results, but that would be hard to avoid. Finally, relatively few behavioral scales were used in this study, which leads to the lack of behavioral support for some results. We will employ more abundant and comprehensive behavioral scales in future studies.

Conclusion

This study found that patients with T2DM with different cognitive states have abnormal hub nodes and functional dysfunction. The brain area of hub nodes and functional dysfunction in patients with DMCI is more extensive and mainly located in vision and memory-related brain regions. Visual-related regions dysfunctions and disconnection may be involved in the neuropathology of visuospatial function impairment in patients with DMCI. This study provides valuable insights into the neurological underpinnings of T2DM-related cognitive impairment.

Data availability statement

The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding authors.

Ethics statement

The studies involving human participants were reviewed and approved by the Ethics Committee of Shaanxi Provincial People's Hospital. The patients/participants provided their written informed consent to participate in this study.

Author contributions

YH and DZ drafted the manuscript and designed the experiment. YH performed the statistical analysis. XinZ, MC, and ZY collected the data. MT and JG contributed to performing the experiments and revising the manuscript. KA provided technical support. XL and XiaZ made contributions to the design of the experiment and revised the manuscript. All authors read and approved the final manuscript.

Funding

This research was supported by the National Natural Science Foundation of China (82170820) and the Key Research and Development Program of Shaanxi Province of China (2018ZDXM-SF-038).

Conflict of interest

Author KA was employed by company Philips Healthcare.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. (2017) 389:2239–51. doi: 10.1016/S0140-6736(17)30058-2

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Sadanand S, Balachandar R, Bharath S. Memory and executive functions in persons with type 2 diabetes: a meta-analysis. Diabetes Metab Res Rev. (2016) 32:132–42. doi: 10.1002/dmrr.2664

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Zhou Y, Fang R, Liu LH, Chen SD, Tang HD. Clinical characteristics for the relationship between type-2 diabetes mellitus and cognitive impairment: a cross-sectional study. Aging Dis. (2015) 6:236–44. doi: 10.14336/AD.2014.1004

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Moran C, Phan TG, Chen J, Blizzard L, Beare R, Venn A, et al. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care. (2013) 36:4036–42. doi: 10.2337/dc13-0143

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Dai Z, He Y. Disrupted structural and functional brain connectomes in mild cognitive impairment and Alzheimer's disease. Neurosci Bull. (2014) 30:217–32. doi: 10.1007/s12264-013-1421-0

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Li C, Li C, Yang Q, Wang B, Yin X, Zuo Z, et al. Cortical thickness contributes to cognitive heterogeneity in patients with type 2 diabetes mellitus. Medicine. (2018) 97:e10858. doi: 10.1097/MD.0000000000010858

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Li W, Risacher SL, Huang E, Saykin AJ, Alzheimer's Disease Neuroimaging Initiative. Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort. Neurology. (2016) 87:595–600. doi: 10.1212/WNL.0000000000002950

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Kumar R, Looi JC, Raphael B. Type 2 diabetes mellitus, cognition and brain in aging: a brief review. Ind J Psychiatry. (2009) 51 (Suppl. S1):35–8.

PubMed Abstract | Google Scholar

9. Zhang Y, Zhang X, Zhang J, Liu C, Yuan Q, Yin X, et al. Gray matter volume abnormalities in type 2 diabetes mellitus with and without mild cognitive impairment. Neurosci Lett. (2014) 562:1–6. doi: 10.1016/j.neulet.2014.01.006

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Li C, Zuo Z, Liu D, Jiang R, Li Y, Li H, et al. Type 2 diabetes mellitus may exacerbate gray matter atrophy in patients with early-onset mild cognitive impairment. Front Neurosci. (2020) 14:856. doi: 10.3389/fnins.2020.00856

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Gao S, Chen Y, Sang F, Yang Y, Xia J, Li X, et al. White matter microstructural change contributes to worse cognitive function in patients with type 2 diabetes. Diabetes. (2019) 68:2085–94. doi: 10.2337/db19-0233

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Xiong Y, Zhang S, Shi J, Fan Y, Zhang Q, Zhu W. Application of neurite orientation dispersion and density imaging to characterize brain microstructural abnormalities in type-2 diabetics with mild cognitive impairment. J Magn Reson Imaging. (2019) 50:889–98. doi: 10.1002/jmri.26687

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Xiong Y, Sui Y, Xu Z, Zhang Q, Karaman MM, Cai K, et al. A diffusion tensor imaging study on white matter abnormalities in patients with type 2 diabetes using tract-based spatial statistics. AJNR Am J Neuroradiol. (2016) 37:1462–9. doi: 10.3174/ajnr.A4740

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Xiong Y, Tian T, Fan Y, Yang S, Xiong X, Zhang Q, et al. Diffusion tensor imaging reveals altered topological efficiency of structural networks in type-2 diabetes patients with and without mild cognitive impairment. J Magn Reson Imaging. (2022). 55:917–27. doi: 10.1002/jmri.27884

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Li C, Zhang J, Qiu M, Liu K, Li Y, Zuo Z, et al. Alterations of brain structural network connectivity in type 2 diabetes mellitus patients with mild cognitive impairment. Front Aging Neurosci. (2020) 12:615048. doi: 10.3389/fnagi.2020.615048

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Qian H, Qin D, Qi S, Teng Y, Li C, Yao Y, et al. Less is better: single-digit brain functional connections predict T2DM and T2DM-induced cognitive impairment. Front Neurosci. (2020) 14:588684. doi: 10.3389/fnins.2020.588684

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Xiong Y, Chen X, Zhao X, Fan Y, Zhang Q, Zhu W. Altered regional homogeneity and functional brain networks in type 2 diabetes with and without mild cognitive impairment. Sci Rep. (2020) 10:21254. doi: 10.1038/s41598-020-76495-3

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Yang SQ, Xu ZP, Xiong Y, Zhan YF, Guo LY, Zhang S, et al. Altered intranetwork and internetwork functional connectivity in type 2 diabetes mellitus with and without cognitive impairment. Sci Rep. (2016) 6:32980. doi: 10.1038/srep32980

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Zhang D, Lei Y, Gao J, Qi F, Yan X, Ai K, et al. Right frontoinsular cortex: a potential imaging biomarker to evaluate T2DM-induced cognitive impairment. Front Aging Neurosci. (2021) 13:674288. doi: 10.3389/fnagi.2021.674288

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Liu D, Duan S, Zhou C, Wei P, Chen L, Yin X, et al. Altered brain functional hubs and connectivity in type 2 diabetes mellitus patients: a resting-state fMRI study. Front Aging Neurosci. (2018) 10:55. doi: 10.3389/fnagi.2018.00055

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Li Y, Liang Y, Tan X, Chen Y, Yang J, Zeng H, et al. Altered functional hubs and connectivity in type 2 diabetes mellitus without mild cognitive impairment. Front Neurol. (2020) 11:1016. doi: 10.3389/fneur.2020.01016

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, et al. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci. (2009) 29:1860–73. doi: 10.1523/JNEUROSCI.5062-08.2009

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Telesford QK, Simpson SL, Burdette JH, Hayasaka S, Laurienti PJ. The brain as a complex system: using network science as a tool for understanding the brain. Brain Connect. (2011) 1:295–308. doi: 10.1089/brain.2011.0055

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Bassett DS, Sporns O. Network neuroscience. Nat Neurosci. (2017) 20:353–64. doi: 10.1038/nn.4502

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Guo M, Ren Y, Yu H, Yang H, Cao C, Li Y, et al. Alterations in degree centrality and functional connectivity in Parkinson's disease patients with freezing of gait: a resting-state functional magnetic resonance imaging study. Front Neurosci. (2020) 14:582079. doi: 10.3389/fnins.2020.582079

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Li MG, Bian XB, Zhang J, Wang ZF, Ma L. Aberrant voxel-based degree centrality in Parkinson's disease patients with mild cognitive impairment. Neurosci Lett. (2021) 741:135507. doi: 10.1016/j.neulet.2020.135507

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Collij LE, Ingala S, Top H, Wottschel V, Stickney KE, Tomassen J, et al. White matter microstructure disruption in early stage amyloid pathology. Alzheimer's Dement. (2021) 13:e12124. doi: 10.1002/dad2.12124

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Kennedy KM, Foster CM, Rodrigue KM. Increasing beta-amyloid deposition in cognitively healthy aging predicts non-linear change in BOLD modulation to difficulty. Neuroimage. (2018) 183:142–9. doi: 10.1016/j.neuroimage.2018.08.017

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Rabin LA, Barr WB, Burton LA. Assessment practices of clinical neuropsychologists in the United States and Canada: a survey of INS, NAN, and APA Division 40 members. Arch Clin Neuropsychol. (2005) 20:33–65. doi: 10.1016/j.acn.2004.02.005

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Paula JJ, Miranda DM, Moraes EN, Malloy-Diniz LF. Mapping the clockworks: what does the clock drawing test assess in normal and pathological aging? Arq Neuropsiquiatr. (2013) 71:763–8. doi: 10.1590/0004-282X20130118

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. (2001) 32:1318–22. doi: 10.1161/01.STR.32.6.1318

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Yan CG, Wang XD, Zuo XN, Zang YF. DPABI: data processing & analysis for (resting-state) brain imaging. Neuroinformatics. (2016) 14:339–51. doi: 10.1007/s12021-016-9299-4

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage. (2012) 59:2142–54. doi: 10.1016/j.neuroimage.2011.10.018

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Yan CG, Cheung B, Kelly C, Colcombe S, Craddock RC, Di Martino A, et al. A comprehensive assessment of regional variation in the impact of head micromovements on functional connectomics. Neuroimage. (2013) 76:183–201. doi: 10.1016/j.neuroimage.2013.03.004

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Li S, Ma X, Huang R, Li M, Tian J, Wen H, et al. Abnormal degree centrality in neurologically asymptomatic patients with end-stage renal disease: a resting-state fMRI study. Clin Neurophysiol. (2016) 127:602–9. doi: 10.1016/j.clinph.2015.06.022

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Zuo XN, Xing XX. Test-retest reliabilities of resting-state FMRI measurements in human brain functional connectomics: a systems neuroscience perspective. Neurosci Biobehav Rev. (2014) 45:100–18. doi: 10.1016/j.neubiorev.2014.05.009

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Machielsen WC, Rombouts SA, Barkhof F, Scheltens P, Witter MP. FMRI of visual encoding: reproducibility of activation. Hum Brain Mapp. (2000) 9:156–64. doi: 10.1002/(SICI)1097-0193(200003)9:3<156::AID-HBM4>3.0.CO;2-Q

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Li W, Sun L, Li G, Xiao S. Prevalence, influence factors and cognitive characteristics of mild cognitive impairment in type 2 diabetes mellitus. Front Aging Neurosci. (2019) 11:180. doi: 10.3389/fnagi.2019.00180

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Wen L, Wang Y, Lin Z, Wang FH, Ding XX, Li D, et al. The prevalence and causes of visual impairment in type 2 diabetes mellitus in northeast China. J Ophthalmol. (2020) 2020:5969816. doi: 10.1155/2020/5969816

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Gao Y, Xiao Y, Miao R, Zhao J, Zhang W, Huang G, et al. The characteristic of cognitive function in type 2 diabetes mellitus. Diabetes Res Clin Pract. (2015) 109:299–305. doi: 10.1016/j.diabres.2015.05.019

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol. (2004) 26:1044–80. doi: 10.1080/13803390490514875

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Weiner KS, Zilles K. The anatomical and functional specialization of the fusiform gyrus. Neuropsychologia. (2016) 83:48–62. doi: 10.1016/j.neuropsychologia.2015.06.033

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Cai S, Chong T, Zhang Y, Li J, von Deneen KM, Ren J, et al. Altered functional connectivity of fusiform gyrus in subjects with amnestic mild cognitive impairment: a resting-state fMRI study. Front Hum Neurosci. (2015) 9:471. doi: 10.3389/fnhum.2015.00471

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Bokde AL, Lopez-Bayo P, Meindl T, Pechler S, Born C, Faltraco F, et al. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment. Brain. (2006) 129(Pt 5):1113–24. doi: 10.1093/brain/awl051

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Squire LR, Dede AJ. Conscious and unconscious memory systems. Cold Spring Harb Perspect Biol. (2015) 7:a021667. doi: 10.1101/cshperspect.a021667

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Danielson NB, Guo JN, Blumenfeld H. The default mode network and altered consciousness in epilepsy. Behav Neurol. (2011) 24:55–65. doi: 10.1155/2011/912720

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Seeley WW, Menon V, Schatzberg AF, Keller J, Glover GH, Kenna H, et al. Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci. (2007) 27:2349–56. doi: 10.1523/JNEUROSCI.5587-06.2007

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Kim DJ, Yu JH, Shin MS, Shin YW, Kim MS. Hyperglycemia reduces efficiency of brain networks in subjects with type 2 diabetes. PLoS ONE. (2016) 11:e0157268. doi: 10.1371/journal.pone.0157268

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Cai C, Huang C, Yang C, Zhang X, Peng Y, Zhao W, et al. Altered patterns of phase position connectivity in default mode subnetwork of subjective cognitive decline and amnestic mild cognitive impairment. Front Neurosci. (2020) 14:185. doi: 10.3389/fnins.2020.00185

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Xue C, Yuan B, Yue Y, Xu J, Wang S, Wu M, et al. Distinct disruptive patterns of default mode subnetwork connectivity across the spectrum of preclinical Alzheimer's disease. Front Aging Neurosci. (2019) 11:307. doi: 10.3389/fnagi.2019.00307

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Foster CM, Kennedy KM, Horn MM, Hoagey DA, Rodrigue KM. Both hyper- and hypo-activation to cognitive challenge are associated with increased beta-amyloid deposition in healthy aging: a non-linear effect. Neuroimage. (2018) 166:285–92. doi: 10.1016/j.neuroimage.2017.10.068

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Popescu SG, Whittington A, Gunn RN, Matthews PM, Glocker B, Sharp DJ, et al. Non-linear biomarker interactions in conversion from mild cognitive impairment to Alzheimer's disease. Hum Brain Mapp. (2020) 41:4406–18. doi: 10.1002/hbm.25133

PubMed Abstract | CrossRef Full Text | Google Scholar

53. Osher Y, Dobron A, Belmaker RH, Bersudsky Y, Dwolatzky T. Computerized testing of neurocognitive function in euthymic bipolar patients compared to those with mild cognitive impairment and cognitively healthy controls. Psychother Psychosom. (2011) 80:298–303. doi: 10.1159/000324508

PubMed Abstract | CrossRef Full Text | Google Scholar

54. Eshkoor SA, Hamid TA, Mun CY, Ng CK. Mild cognitive impairment and its management in older people. Clin Interv Aging. (2015) 10:687–93. doi: 10.2147/CIA.S73922

PubMed Abstract | CrossRef Full Text | Google Scholar

55. Nasr S, Tootell RB. Role of fusiform and anterior temporal cortical areas in facial recognition. Neuroimage. (2012) 63:1743–53. doi: 10.1016/j.neuroimage.2012.08.031

PubMed Abstract | CrossRef Full Text | Google Scholar

56. Picard C, Nilsson N, Labonté A, Auld D, Rosa-Neto P, Alzheimer's Disease Neuroimaging Initiative, et al. Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease. Alzheimer's Dement. (2022) 18:875–87. doi: 10.1002/alz.12442

PubMed Abstract | CrossRef Full Text | Google Scholar

57. Bedse G, Di Domenico F, Serviddio G, Cassano T. Aberrant insulin signaling in Alzheimer's disease: current knowledge. Front Neurosci. (2015) 9:204. doi: 10.3389/fnins.2015.00204

PubMed Abstract | CrossRef Full Text | Google Scholar

58. Uddin LQ, Supekar K, Amin H, Rykhlevskaia E, Nguyen DA, Greicius MD, et al. Dissociable connectivity within human angular gyrus and intraparietal sulcus: evidence from functional and structural connectivity. Cereb Cortex. (2010) 20:2636–46. doi: 10.1093/cercor/bhq011

PubMed Abstract | CrossRef Full Text | Google Scholar

59. Rushworth MF, Behrens TE, Johansen-Berg H. Connection patterns distinguish 3 regions of human parietal cortex. Cereb Cortex. (2006) 16:1418–30. doi: 10.1093/cercor/bhj079

PubMed Abstract | CrossRef Full Text | Google Scholar

60. Rugg MD, King DR. Ventral lateral parietal cortex and episodic memory retrieval. Cortex. (2018) 107:238–50. doi: 10.1016/j.cortex.2017.07.012

PubMed Abstract | CrossRef Full Text | Google Scholar

61. Seghier ML. The angular gyrus: multiple functions and multiple subdivisions. Neuroscientist. (2013) 19:43–61. doi: 10.1177/1073858412440596

PubMed Abstract | CrossRef Full Text | Google Scholar

62. Boccia M, Teghil A, Guariglia C. Looking into recent and remote past: meta-analytic evidence for cortical re-organization of episodic autobiographical memories. Neurosci Biobehav Rev. (2019) 107:84–95. doi: 10.1016/j.neubiorev.2019.09.003

PubMed Abstract | CrossRef Full Text | Google Scholar

63. Sestieri C, Corbetta M, Romani GL, Shulman GL. Episodic memory retrieval, parietal cortex, and the default mode network: functional and topographic analyzes. J Neurosci. (2011) 31:4407–20. doi: 10.1523/JNEUROSCI.3335-10.2011

PubMed Abstract | CrossRef Full Text | Google Scholar

64. Du X, Zhang Y, Zhao Q, Qin W, Ma G, Fu J, et al. Effects of INSR genetic polymorphism on hippocampal volume and episodic memory in Chinese type 2 diabetes. Acta Diabetol. (2021) 58:1471–80. doi: 10.1007/s00592-021-01750-6

PubMed Abstract | CrossRef Full Text | Google Scholar

65. Wei T, Liang X, He Y, Zang Y, Han Z, Caramazza A, et al. Predicting conceptual processing capacity from spontaneous neuronal activity of the left middle temporal gyrus. J Neurosci. (2012) 32:481–9. doi: 10.1523/JNEUROSCI.1953-11.2012

PubMed Abstract | CrossRef Full Text | Google Scholar

66. Yan H, Zhang Y, Chen H, Wang Y, Liu Y. Altered effective connectivity of the default mode network in resting-state amnestic type mild cognitive impairment. J Int Neuropsychol Soc. (2013) 19:400–9. doi: 10.1017/S1355617712001580

PubMed Abstract | CrossRef Full Text | Google Scholar

67. Chen YC, Jiao Y, Cui Y, Shang SA, Ding J, Feng Y, et al. Aberrant brain functional connectivity related to insulin resistance in type 2 diabetes: a resting-state fMRI study. Diabetes Care. (2014) 37:1689–96. doi: 10.2337/dc13-2127

PubMed Abstract | CrossRef Full Text | Google Scholar

68. Tan X, Liang Y, Zeng H, Qin C, Li Y, Yang J, et al. Altered functional connectivity of the posterior cingulate cortex in type 2 diabetes with cognitive impairment. Brain Imaging Behav. (2019) 13:1699–707. doi: 10.1007/s11682-018-0017-8

PubMed Abstract | CrossRef Full Text | Google Scholar

69. Krajcovicova L, Barton M, Elfmarkova-Nemcova N, Mikl M, Marecek R, Rektorova I. Changes in connectivity of the posterior default network node during visual processing in mild cognitive impairment: staged decline between normal aging and Alzheimer's disease. J Neural Transm. (2017) 124:1607–19. doi: 10.1007/s00702-017-1789-5

PubMed Abstract | CrossRef Full Text | Google Scholar

70. Striepens N, Schröter F, Stoffel-Wagner B, Maier W, Hurlemann R, Scheele D. Oxytocin enhances cognitive control of food craving in women. Hum Brain Mapp. (2016) 37:4276–85. doi: 10.1002/hbm.23308

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: type 2 diabetes mellitus, resting-state functional magnetic resonance imaging, degree centrality, functional connectivity, neuroimaging

Citation: Huang Y, Zhang D, Zhang X, Cheng M, Yang Z, Gao J, Tang M, Ai K, Lei X and Zhang X (2022) Altered functional hubs and connectivity in type 2 diabetes mellitus with and without mild cognitive impairment. Front. Neurol. 13:1062816. doi: 10.3389/fneur.2022.1062816

Received: 06 October 2022; Accepted: 21 November 2022;
Published: 12 December 2022.

Edited by:

Xi-jian Dai, Second Affiliated Hospital of Nanchang University, China

Reviewed by:

Panpan Cheng, Huazhong University of Science and Technology, China
Liang Gong, Chengdu Second People's Hospital, China
Qixiang Lin, Emory University, United States
Xiangyang Xu, Huazhong University of Science and Technology, China

Copyright © 2022 Huang, Zhang, Zhang, Cheng, Yang, Gao, Tang, Ai, Lei and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xiaoling Zhang, zxl.822@163.com; Xiaoyan Lei, 13152180235@163.com

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.